Citations 14

S27 Interobserver Agreement of Modified Paris Classification and Histology Prediction of Colorectal Lesions in Patients With Inflammatory Bowel Disease

American Journal of Gastroenterology | December 5, 2022 | Volume: 117 | Issue: 12S | Pages: S7-S7

10.14309/01.ajg.0000897616.43383.78

S953 Validation of AGA Risk Factors for Prediction of IBD Severity

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S456-S456

10.14309/01.ajg.0000777344.54047.4f

S909 Risk Factors for Colorectal Dysplasia and Colorectal Cancer (CRC) Among Patients With Inflammatory Bowel Disease (IBD) Undergoing Surveillance Colonoscopy in a Tertiary Care Center

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S430-S430

10.14309/01.ajg.0000777168.32638.87

Vulvar Crohn's Disease: Clinical Features and Outcomes

American Journal of Gastroenterology | September 9, 2021 | Volume: 116 | Issue: 11 | Pages: 2296-2299

10.14309/ajg.0000000000001502 | PMID 34732676

INTRODUCTION: Vulvar involvement is a rare complication of Crohn's disease (CD). The optimal treatment of vulvar CD is unknown. METHODS: We conducted a 25-year retrospective cohort study of vulvar CD from 3 referral centers. Clinical features and outcomes were studied. RESULTS: Fifty patients were identified. The most common vulvar symptoms were pain (74%), edema (60%), ulcerations (46%), nodules (36%), and abscess (34%). Medical management leading to symptomatic improvement varied, and 5 patients ultimately required surgery. DISCUSSION: Vulvar CD manifests with a broad spectrum of symptoms. Aggressive medical management was frequently effective, although surgery was required in 10% of cases.